马耳他 -
英文 -
Medicines Authority
cisplatin 1mg/ml (10ml vial) concentrate for solution for infusion
cipla (eu) limited hillbrow house, hillbrow road, esher, surrey, kt10 9nw, united kingdom - cisplatin - concentrate for solution for infusion - cisplatin 1 mg/ml - antineoplastic agents
马耳他 -
英文 -
Medicines Authority
cisplatin 1 mg/ml (50ml vial) concentrate for solution for infusion
cipla (eu) limited hillbrow house, hillbrow road, esher, surrey, kt10 9nw, united kingdom - cisplatin - concentrate for solution for infusion - cisplatin 1 mg/ml - antineoplastic agents
马耳他 -
英文 -
Medicines Authority
cisplatin 1 mg/ml (100ml vial) concentrate for solution for infusion
cipla (eu) limited hillbrow house, hillbrow road, esher, surrey, kt10 9nw, united kingdom - cisplatin - concentrate for solution for infusion - cisplatin 1 mg/ml - antineoplastic agents
马耳他 -
英文 -
Medicines Authority
cisplatin teva concentrate for soln for inf 1mg/ml (50mg vial)
teva pharma b.v. swensweg 5, 2031 ga haarlem, netherlands - cisplatin - concentrate for solution for infusion - cisplatin 1 mg/ml - antineoplastic agents
马耳他 -
英文 -
Medicines Authority
cisplatin teva concentrate for soln for inf 1mg/ml (100mg vial)
teva pharma b.v. swensweg 5, 2031 ga haarlem, netherlands - cisplatin - concentrate for solution for infusion - cisplatin 1 mg/ml - antineoplastic agents
澳大利亚 -
英文 -
Department of Health (Therapeutic Goods Administration)
dbl cisplatin 100mg/100ml injection
pfizer australia pty ltd - cisplatin, quantity: 1 mg/ml - injection, solution - excipient ingredients: mannitol; water for injections; sodium chloride - cisplatin injection is indicated for the palliative treatment of metastatic non-seminomatous germ cell carcinoma, advanced-stage refractory ovarian carcinoma, advanced-stage refractory bladder carcinoma and refractory squamous cell carcinoma of the head and neck. it may be used as a single agent or in combination with other chemotherapeutic agents. it may be employed, in appropriate circumstances, in addition to other modalities, eg radiotherapy or surgery.
澳大利亚 -
英文 -
Department of Health (Therapeutic Goods Administration)
dbl cisplatin 50mg/50ml injection
pfizer australia pty ltd - cisplatin, quantity: 1 mg/ml - injection, solution - excipient ingredients: sodium chloride; mannitol; water for injections - cisplatin injection is indicated for the palliative treatment of metastatic non-seminomatous germ cell carcinoma, advanced-stage refractory ovarian carcinoma, advanced-stage refractory bladder carcinoma and refractory squamous cell carcinoma of the head and neck. it may be used as a single agent or in combination with other chemotherapeutic agents. it may be employed, in appropriate circumstances, in addition to other modalities, eg radiotherapy or surgery.
马耳他 -
英文 -
Medicines Authority
cisplatin 1 mg/ml concentrate for solution for infusion (10ml vial)
pfizer hellas s.a. 243 messoghion ave., neo psychiko 15451, athens, greece - cisplatin - concentrate for solution for infusion - cisplatin 1 mg/ml - antineoplastic agents
马耳他 -
英文 -
Medicines Authority
cisplatin 1 mg/ml concentrate for solution for infusion (50ml vial)
pfizer hellas s.a. 243 messoghion ave., neo psychiko 15451, athens, greece - cisplatin - concentrate for solution for infusion - cisplatin 1 mg/ml - antineoplastic agents
马耳他 -
英文 -
Medicines Authority
cisplatin 1 mg/ml concentrate for solution for infusion (100ml vial)
pfizer hellas s.a. 243 messoghion ave., neo psychiko 15451, athens, greece - cisplatin - concentrate for solution for infusion - cisplatin 1 mg/ml - antineoplastic agents